Chris Null is a seasoned professional in the field of experimental design and clinical science, with extensive experience in both industry and research settings. Currently serving as a Study Director at Inotiv since January 2020, Chris previously held the same title at Seventh Wave Laboratories LLC, where responsibilities included developing protocols for non-regulated studies related to agricultural, chemical, pharmaceutical, and biotechnology products. Prior to these roles, Chris was the Director of Clinical Science at Pulse Therapeutics, focusing on preclinical efficacy and safety studies for a novel thrombolysis device, and held the position of Senior Scientist at Pfizer, supporting various animal model studies across multiple therapeutic areas. Chris's foundational experience includes roles at Pharmacia, Monsanto, and G.D. Searle, with a Bachelor of Science degree in Animal Science from the University of Missouri-Columbia.
This person is not in any teams
This person is not in any offices